Corona Milagrow robot 2020

Corona Milagrow robot 2020

Milagrow's robots to be installed in Delhi AIIMS, will help doctors fight Corona

Corona virus is spread all over the world including India. All countries are dealing with Corona according to their respective ways. At the same time, at Delhi AIIMS, robotics brand Milagro has announced to deploy its robot to help doctors. The company says that in a partnership, the advanced AI-powered robot Milagro IMAP 9 and Humanoid ELF robot will be installed in the Kovid-19 ward of Delhi AIIMS.

The Milagro iMap 9 manufactured in India is a floor disinfecting robot that performs automatic work. It uses sodium hypochlorite solution which allows the robot to clean the surface of the floor. This robot is guided by LIDAR and equipped with advanced SLAM technology that prevents the robot from colliding and falling.

Apart from this, these robots have Milagro's patented real-time terrain recognition technology (RT2RT) that performs floor mapping in seconds. The Milagrow Humanoid ELF enables doctors to monitor and interact with infectious Kovid-19 patients without person-to-person contact.

Bored patients in isolation wards can interact with their relatives periodically through this robot. It also has high definition video and audio recording. The company has claimed an eight-hour backup regarding its battery. This robot can run at a speed of 2.9 kmph. It is 92 cm long and has more than 60 sensors, a 3D and an HD camera, and a 10.1-inch display. It also has eyes.

While giving this information, AIIMS director Randeep Guleria said, "Milagrow floor robot IMAP 9.0 and Milagro Humanoid will be tried in AIIMS Hospital in New Delhi." Milagro founder chairman Rajeev Carval said, "Milagro robots are very happy to help AIIMS in their efforts to fight the corona epidemic." We will work together to develop more products based on the feedback we receive under actual conditions.Countries such as the United States (USA), China and Italy have already started using AI-based robots in health facilities to reduce human intervention in the treatment of Kovid-19 patients.